The total return over the past 12 months is -1.78% vs. +16.94% for the S&P 500. So far it's up +0.45% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (2.93%) | +42.28% | +11.56% | +3.13% | N/A | N/A |
| Total Return CAGR | (1.78%) | +45.37% | +14.40% | +5.27% | N/A | N/A |
| Revenue CAGR | +17.12% | +15.79% | +12.75% | +7.28% | +6.28% | +6.92% |
| Net Income CAGR | +106.61% | +45.14% | +12.89% | +1.89% | +4.16% | N/A |
| EPS CAGR | +106.72% | +44.80% | +12.92% | +1.55% | N/A | N/A |
| Free Cash Flow CAGR | (76.41%) | N/A | (12.27%) | +27.55% | N/A | N/A |
| Operating Cash Flow CAGR | (13.94%) | +73.01% | +7.38% | +6.36% | N/A | +24.88% |
| Dividends CAGR | 0.00% | 0.00% | 0.00% | +1.84% | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Phibro Animal Health Corporation (PAHC)
| Year | Start price | End price | PAHC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $37.36 | $37.19 | +0.45% | +14.51% | (14.06%) |
| 2025 | $21.00 | $37.36 | +80.77% | +17.72% | +63.05% |
| 2024 | $11.58 | $21.00 | +86.33% | +24.89% | +61.44% |
| 2023 | $13.41 | $11.58 | (10.34%) | +26.19% | (36.53%) |
| 2022 | $20.42 | $13.41 | (32.33%) | (18.17%) | (14.16%) |
| 2021 | $19.42 | $20.42 | +7.28% | +28.74% | (21.46%) |
| 2020 | $24.83 | $19.42 | (20.11%) | +18.37% | (38.48%) |
| 2019 | $32.16 | $24.83 | (21.32%) | +31.22% | (52.54%) |
| 2018 | $33.50 | $32.16 | (2.99%) | (4.56%) | +1.57% |
| 2017 | $29.30 | $33.50 | +15.73% | +21.70% | (5.97%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
